太極陰陽圖在西醫學解釋模型的創新應用

Innovative Applications on Explanation Model of the Tai- Chi Yin-Yang Symbol in Western Medicine

10.3966/168232812016122604004

蔡崇煌(Chung-Huang Tsai)；王俊堯(Jiun-Yao Wang)；林哲鈺(James Che-Yu Lin)；張金堅(King-Jen Chang)；林正介(Cheng-Chieh Lin)；李孟智(Meng-Chih Lee)；黃素雲(Su-Yun Huang)

波耳 ； 血管張力素 ； 易經 ； 太極陰陽圖 ； Bohr ； angiotensin ； I-Ching ； Tai-Chi yin-yang symbol

台灣家庭醫學雜誌

26卷4期（2016 / 12 / 01）

219 - 227

繁體中文

易經是中國最古老的經書之一，歷經上古時期的伏羲氏、中古時期周文王、及近古時代的孔子傳述，再經數千年的淬鍊，內容不斷增修，形成一完整理論，但現今所見的太極陰陽圖，原是易經書內所無，是後人根據對易經的理解才添加進去的。20世紀量子力學先趨者、丹麥人波耳(Bohr)，提出互補原理(complementarity principle)，榮獲1922年諾貝爾物理學獎，其讚嘆太極陰陽概念可契合於其物理學的研究，甚至把太極陰陽圖作為自己家族的族徽。近來亦有應用易經概念於企業的管理，可見此哲學觀念與其他領域學科可有些交集的應用。膽固醇在體內有著極重要的生理功能，但過量反造成粥狀動脈硬化，此就像是太極陰陽圖中的物極必反。在醫療現象及處置上，常有涉及一物的正反兩面作用、例外及副作用等，我們發現可用太極陰陽圖去解釋，如此可使醫師及患者更快速掌握及了解其內涵，亦可達跨領域的創新應用。本文以血管張力素II受體阻斷劑為例，擴展太極陰陽圖為四象的應用，亦提醒我們在對病人做處置時，需隨時考量其效用、副作用、額外好處或非屬副作用的額外注意事項等。

Book of Changes or I-Ching is one of the most ancient scriptures in China. From Fuxi in ancient times through King Wen of Zhou and Confucius of the Warring States Period to the subsequent millennia, interpretations of the book have been constantly expanded into a highly sophisticated, as well as were complicated, theory. Originally absent in I-Ching, the Tai-Chi yin-yang symbol seen nowadays was added by posterity based on the understanding of the book. Pioneering quantum mechanics in the 20th century and winning the 1922 Nobel Prize in Physics, Niels Bohr was so impressed by the affinity between the Tai-Chi yin-yang symbol and his complementarity principle that he embraced the symbol as his family emblem. More recently, the concepts embodied in the symbol have also been applied to business management, further indicating the existence of intersections between the cultural and philosophical concepts of the East and the sciences of the West. In medical science, for example, cholesterol in human body plays important physiological functions, but excessiveness can cause atherosclerosis; this echoes the Tai-Chi yin-yang idea that things tend to develop in the opposite direction when they are pushed to the extreme. In medicine, there are plenty of exceptions, side effects, and drugs or treatments that can both heal and hurt; applying the Tai-chi yin-yang theory in an innovative, cross-disciplinary manner may help physicians, as well as patients, better understand their meanings and explore their implications. In this article, angiotensin II receptor blockers were used to extend the application of Tai-Chi yin-yang symbol to the concept of the four quadrants. It reminds physicians of the need to consider their treatment's effectiveness, side effects, additional benefits, and precautions not related to side effects.

1. 蔡崇煌、林哲鈺、黃素雲、王俊堯、李孟智(2014)。失眠於生物心理心靈社會面向之壓力─資源／調適模型圖的考量。臺灣家醫誌，24，49-62。
   連結：
2. 蔡崇煌、蔡新聲、黃青真、林哲鈺、張金堅、李孟智(2012)。西方現代科技八股文與中文起承轉合在醫學論文寫作應用之探討。臺灣家醫誌，22，96-106。
   連結：
3. 一中老師的變性告白：從曾國昌變曾愷芯，我心裡一直住著一個女人。2015年9月20日，取自http://womany.net/read/article/7203。
4. 賴秀穗：畜牧場濫用抗生素應予重視。2015年9月20日，取自http://www.chikung.org.tw/ txt/news/news0012.htm。
5. (2002).Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
6. (1994).Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).Lancet,344,1383-9.
7. Cox, LM,Yamanishi, S,Sohn, J(2014).Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences.Cell,158,705-21.
8. Jess, T(2014).Microbiota, antibiotics, and obesity.N Engl J Med,371,2526-8.
9. Kohli, P,Waters, DD,Nemr, R(2015).Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL.J Am Coll Cardiol,65,402-4.
10. Kurtz, TW,Pravenec, M(2004).Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system.J Hypertens,22,2253-61.
11. Mostofsky, E,Rice, MS,Levitan, EB,Mittleman, MA(2012).Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis.Circ Heart Fail,5,401-5.
12. Muhlestein, JB,May, HT,Lappé, DL,Bair, TL,Le, VT,Anderson, JL(2014).how low should you go in secondary prevention treatment of ldl cholesterol: observational insights from the intermountain heart collaborative study.Circulation,130,A14994.
13. Nissen, SE,Wolski, K(2007).Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.N Engl J Med,356,2457-71.
14. Preiss, D,Seshasai, SR,Welsh, P(2011).Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.JAMA,305,2556-64.
15. Rajpathak, SN(2012).Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events.Evid Based Med,17,55-6.
16. Spann, NJ,Glass, CK(2013).Sterols and oxysterols in immune cell function.Nat Immunol,14,893-900.
17. Zhao, L(2013).The gut microbiota and obesity: from correlation to causality.Nat Rev Microbiol,11,639-47.
18. 朱熹注、黃慶萱導讀(1997)。易本義（易經）。臺北:金楓出版社。
19. 張金堅、蔡崇煌、林肇堂(2015)。肥胖與腸內菌的相關性。臺灣醫界雜誌，58，16-20。
20. 陳明德(2014)。易經與管理：時乘六龍經營天下的秘訣。新台北:中華奉元。
21. 鍾任琴、黃建岡、楊長春。,未出版